Literature DB >> 18973100

Allergen-sensitization increases mast-cell expression of the exocytotic proteins SNAP-23 and syntaxin 4, which are involved in histamine secretion.

E Salinas1, A Quintanar-Stephano, L E Córdova, J L Ouintanar.   

Abstract

BACKGROUND: Activation of mast cells (MCs) via aggregation of immunoglobulin E (IgE) bound to its high affinity receptor (FcepsilonRI) results in release of inflammatory mediators from secretory granules. Histamine is one of the critical biological mediators released in the allergic response. Synaptosomal-associated protein of 23 kDa (SNAP-23) and syntaxin 4 are plasma membrane proteins that have been associated with exocytosis in MCs. Studies with monoclonal IgEs indicate that binding of IgE to FcepsilonRI induces molecular and biological changes in
OBJECTIVES: The aim of this study was to investigate changes in the expression of SNAP-23 and syntaxin 4 by MCs following rat sensitization with ovalbumin (OVA). In addition, we assessed whether these proteins were involved in histamine secretion.
METHODS: SNAP-23 and syntaxin 4 expression was analyzed by Western blot using MCs from control and sensitized animals. Successful sensitization was confirmed based on the passive cutaneous anaphylaxis reaction. To test the role of these exocytotic proteins in histamine secretion, permeabilized MCs were incubated with SNAP-23 and syntaxin 4 antibodies.
RESULTS: Expression of SNAP-23 and syntaxin 4 was significantly higher in MCs from OVA-sensitized rats than in cells from control animals. In addition, incubation of permabilized cells with antibodies to SNAP-23 and syntaxin 4 led to a marked reduction of histamine secretion in stimulated cells.
CONCLUSIONS: Sensitization with OVA increases the expression of SNAP-23 and syntaxin 4 in MCs. Furthermore, our data suggest that these exocytotic proteins participate in histamine secretion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18973100

Source DB:  PubMed          Journal:  J Investig Allergol Clin Immunol        ISSN: 1018-9068            Impact factor:   4.333


  6 in total

1.  Munc18-2, but not Munc18-1 or Munc18-3, controls compound and single-vesicle-regulated exocytosis in mast cells.

Authors:  Berenice A Gutierrez; Miguel A Chavez; Alejandro I Rodarte; Marco A Ramos; Andrea Dominguez; Youlia Petrova; Alfredo J Davalos; Renan M Costa; Ramon Elizondo; Michael J Tuvim; Burton F Dickey; Alan R Burns; Ruth Heidelberger; Roberto Adachi
Journal:  J Biol Chem       Date:  2018-03-29       Impact factor: 5.157

Review 2.  The impact of bacterial infection on mast cell degranulation.

Authors:  Jordan Wesolowski; Fabienne Paumet
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

3.  Polyphenols differentially inhibit degranulation of distinct subsets of vesicles in mast cells by specific interaction with granule-type-dependent SNARE complexes.

Authors:  Yoosoo Yang; Jung-Mi Oh; Paul Heo; Jae Yoon Shin; Byoungjae Kong; Jonghyeok Shin; Ji-Chun Lee; Jeong Su Oh; Kye Won Park; Choong Hwan Lee; Yeon-Kyun Shin; Dae-Hyuk Kweon
Journal:  Biochem J       Date:  2013-03-15       Impact factor: 3.857

4.  Escherichia coli exposure inhibits exocytic SNARE-mediated membrane fusion in mast cells.

Authors:  Jordan Wesolowski; Fabienne Paumet
Journal:  Traffic       Date:  2014-03-07       Impact factor: 6.215

5.  Syntaxin 3, but not syntaxin 4, is required for mast cell-regulated exocytosis, where it plays a primary role mediating compound exocytosis.

Authors:  Elizabeth Sanchez; Erika A Gonzalez; David S Moreno; Rodolfo A Cardenas; Marco A Ramos; Alfredo J Davalos; John Manllo; Alejandro I Rodarte; Youlia Petrova; Daniel C Moreira; Miguel A Chavez; Alejandro Tortoriello; Adolfo Lara; Berenice A Gutierrez; Alan R Burns; Ruth Heidelberger; Roberto Adachi
Journal:  J Biol Chem       Date:  2018-12-18       Impact factor: 5.157

Review 6.  SNARE complex-mediated degranulation in mast cells.

Authors:  Joseph R Woska; Marc E Gillespie
Journal:  J Cell Mol Med       Date:  2012-04       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.